Postmenopausal breast cancer: European challenge and innovative concepts

. 2017 Jun ; 8 (2) : 159-169. [epub] 20170530

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid28824739

Breast cancer (BC) epidemic is recognised now worldwide as the reality of the early twenty-first century. Increasing trends in the postmenopausal BC prevalence, even for the European countries earlier demonstrating relatively stable incidence rates of the disease, are highly alarming for the healthcare givers. This new actuality requires a substantial revision of the paradigm currently applied to the BC management and creation of highly innovative concepts. Current multi-centred study highlights new complex mechanisms of the development and progression of the postmenopausal BC. Innovative concepts are presented which argue for more effective predictive and preventive approaches well justified in view of the clusters of the symptoms analysed here and demonstrated as highly prevalent in the postmenopausal breast cancer versus BC-free individuals. Another conceptual novelty presented here is a new interpretation of the "Seed and Soil" theory of metastasis in BC. According to the new concept, the "pre-metastatic niches" ("Soil") are created by a systemic hypoxia a long time before the breast malignancy is clinically manifested.

Zobrazit více v PubMed

Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, Grech G. Breast cancer epidemic in the early 21st century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. 2016;37(10):12941–12957. doi: 10.1007/s13277-016-5168-x. PubMed DOI

Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, Renehan AG, Forman D, Soerjomataram I. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer. 2015;51(9):1164–1187. doi: 10.1016/j.ejca.2013.09.002. PubMed DOI

Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J 2017; 8(1):17–22. doi:10.1007/s13167-017-0086-6. PubMed PMC

Zubor P, Gondova A, Polivka J, Jr, Kasajova P, Konieczka K, Danko J, Golubnitschaja O. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017 PubMed PMC

Bubnov R, Polivka J, Jr, Zubor P, Koniczka K, Golubnitschaja O. “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the question. EPMA J. 2017 PubMed PMC

Kokolus K, Hing CC, Repasky EA. Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperth. 2010;26(7):662–680. doi: 10.3109/02656736.2010.507235. PubMed DOI PMC

Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol. 2015;12(10):588–596. doi: 10.1038/nrcardio.2015.105. PubMed DOI

Golubnitschaja O, Debald M, Kuhn W, Yeghiazaryan K, Bubnov RV, Goncharenko VM, Lushchyk U, Grech G, Konieczka K. Flammer syndrome and potential formation of pre-metastatic niches: a multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease. EPMA J. 2016;7(Suppl 1):9.

Cox TR, Rumney RM, Schoof EM, Perryman L, Hoye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522:106–110. doi: 10.1038/nature14492. PubMed DOI PMC

Vanharanta S. A hypoxic ticket to the bone metastatic niche. Breast Cancer Res. 2015;17(1):122. doi: 10.1186/s13058-015-0635-7. PubMed DOI PMC

Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K. Flammer syndrome. EPMA J. 2014;5(1):11. doi: 10.1186/1878-5085-5-11. PubMed DOI PMC

Yeghiazaryan K, Flammer J, Orgül S, Wunderlich K, Golubnitschaja O. Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes. Mol Vis. 2009;15:2339–2348. PubMed PMC

Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4(1):14. doi: 10.1186/1878-5085-4-14. PubMed DOI PMC

Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263–272. doi: 10.1007/s13167-010-0032-3. PubMed DOI PMC

Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? EPMA J. 2010;1(2):237–244. doi: 10.1007/s13167-010-0031-4. PubMed DOI PMC

Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J. 2013;4(1):6. doi: 10.1186/1878-5085-4-6. PubMed DOI PMC

Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM. Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monatsbl Augenheilkd. 2014;231(4):344–347. doi: 10.1055/s-0034-1368239. PubMed DOI

Konieczka K, Fränkl S. Primäre vaskuläre Dysregulation und Glaukom (Primary vascular dysregulation and glaucoma) Z prakt Augenheilkd. 2013;34:207–215.

Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome) EPMA J. 2016;7:13. doi: 10.1186/s13167-016-0062-6. PubMed DOI PMC

Konieczka K, Koch S, Schoetzau A, Todorova MG. Increased prevalence of Flammer syndrome in patients with retinitis Pigmentosa. Klin Monatsbl Augenheilkd. 2016;233(4):448–452. doi: 10.1055/s-0041-111802. PubMed DOI

Konieczka K, Todorova MG, Chackathayil TN, Henrich PB. Cilioretinal artery occlusion in a young patient with flammer syndrome and increased retinal venous pressure. Klin Monatsbl Augenheilkd. 2015;232(4):576–578. doi: 10.1055/s-0035-1545774. PubMed DOI

Konieczka K, Flammer J, Sternbuch J, Binggeli T, Fraenkl S. Leber’s hereditary optic neuropathy, normal tension glaucoma, and Flammer syndrome: long term follow-up of a patient. Klin Monatsbl Augenheilkd. 2017 PubMed

Health Consumer Powerhouse. Eurohealth Consumer Index Report, 2014. Taby, Sweden: Health Consumer Powerhouse. http://www.healthpowerhouse.com/files/EHCI_2014/EHCI_2014_report.pdf. Accessed on 22 Jan 2017.

Smokovski I, Milenkovic T, Trapp C, Mitov A. Diabetes Care in Republic of Macedonia: challenges and opportunities. Annals of Global Health. 2015;81(6):792–802. doi: 10.1016/j.aogh.2015.12.017. PubMed DOI

Ministry of Health of Republic of Macedonia. National guidelines for medical care of breast cancer, 2015. http://zdravstvo.gov.mk/wp-content/uploads/2015/08/Rak-na-dojka.pdf. Accessed on 22 Jan 2017.

Gershan V, Antevska-Grujoska S. Performance of mammography equipment in the Macedonian breast screening campaign 2008/2009. Radiat Prot Dosim. 2011;147(1–2):187–191. doi: 10.1093/rpd/ncr290. PubMed DOI

Gjorgov NA. Breast cancer risk assessments to barrier contraception exposure. A new approach. Prilozi. 2009;30(1):217–232. PubMed

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–814. doi: 10.1001/jama.2014.732. PubMed DOI PMC

Overweight and obesity—BMI statistics [database on the Internet]. Eurostat. http://ec.europa.eu/eurostat/statistics-explained/index.php/Overweight_and_obesity_-_BMI_statistics Accessed on 28 March 2017.

Arnold M, Freisling H, Stolzenberg-Solomon R, Kee F, O'Doherty MG, Ordóñez-Mena JM, Wilsgaard T, May AM, Bueno-de-Mesquita HB, Tjønneland A, Orfanos P, Trichopoulou A, Boffetta P, Bray F, Jenab M, Soerjomataram I, CHANCES consortium Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol. 2016;31(9):893–904. doi: 10.1007/s10654-016-0169-z. PubMed DOI PMC

Horn-Ross PL, Canchola AJ, Bernstein L, Neuhausen SL, Nelson DO, Reynolds P. Lifetime body size and estrogen-receptor-positive breast cancer risk in the California teachers study cohort. Breast Cancer Res. 2016;18(1):132. doi: 10.1186/s13058-016-0790-5. PubMed DOI PMC

Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, Berkey CS, Colditz GA. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017;140(9):2003–2014. doi: 10.1002/ijc.30627. PubMed DOI PMC

Cebioglu M, Schild HH, Golubnitschaja O. Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J. 2010;1(1):130–137. doi: 10.1007/s13167-010-0015-4. PubMed DOI PMC

Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(11):3116–3122. doi: 10.1158/1055-9965.EPI-08-0527. PubMed DOI PMC

Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, Michael Y, O’Sullivan MJ, Stefanick ML, Prentice R. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010;28(6):1005–1010. doi: 10.1200/JCO.2009.25.0423. PubMed DOI PMC

Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013;274(2):113–126. doi: 10.1111/joim.12084. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...